1STBIO and LigaChemBio Announce Strategic R&D and Licensing Option Agreement
Expanded collaboration leverages complementary expertise to unlock next-generation oncology therapeutics Focus on breakthrough ADC payloads and immuno-oncology candidates with out-licensing…
